OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Greenleaf Health, Inc.
Kalah Auchincloss, senior vice-president and deputy general counsel, Greenleaf Health, Inc.
April 14, 2021
This article explores the evolution of FDA’s approach to inspections of drug and biologics manufacturing facilities during the COVID-19 pandemic.